Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Ovarian Epithelial × Counseling × Clear all

Sponsor

Conditions

Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Tobacco Use Disorder 1 Tobacco Smoking 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Sleep Wake Disorders 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Prostate Adenocarcinoma 1 Postoperative Complications 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 Mouth Neoplasms 1 Lung Neoplasms 1 Liver Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Laryngeal Neoplasms 1 Kidney Neoplasms 1 Hypopharyngeal Neoplasms 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Colorectal Neoplasms, Hereditary Nonpolyposis 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1

Interventions

Paclitaxel 22 Carboplatin 18 liposomal doxorubicin 14 Bevacizumab 9 Topotecan 8 Docetaxel 8 Gemcitabine 7 Cisplatin 7 rucaparib 6 pembrolizumab 6 mirvetuximab soravtansine 5 Cyclophosphamide 5 Taxes 4 Albumin-Bound Paclitaxel 4 sargramostim 3 ixabepilone 3 Cytoreduction Surgical Procedures 3 CCV-AV protocol 3 130-nm albumin-bound paclitaxel 3 taxane 2 talazoparib 2 pazopanib 2 olaparib 2 fludarabine phosphate 2 fludarabine 2 denileukin diftitox 2 cediranib 2 catumaxomab 2 belinostat 2 avelumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡